OncoLens which is a Health Tech startup and working on cancer treatment has raised around $16 Million from Cross Border Impact Ventures and BIP Capital and also includes existing investors , SeedToB Capital and Martin Ventures.
OncoLens has raised $16 million in a Series B financing round